Kylo Peptides Quality Standards: specifications, verification, and the standards behind every batch
Our core principle is simple: every batch must produce a Certificate of Analysis that holds up to independent verification. That means written specifications with numerical criteria, compendial test methods, an independent third-party laboratory, retained samples, and a documented protocol for what happens when a batch is out of spec.
Three principles run through every decision
- Specifications are written before the test is run. Every catalog peptide has written acceptance criteria for identity, purity, content, and contamination, set before testing, never adjusted to match a result.
- The lab that issues the result is independent of the lab that made the material. Methods run at FreedomDiagnostics; the financial relationship is documented, and independence is structural, not a marketing claim.
- Every analytical claim is traceable to a method, a lot, and an instrument record. The HPLC chromatogram is the actual trace from a specific synthesis lot, indexed in the COA Library and re-pullable.
Compound specifications & acceptance criteria
Every catalog peptide has a written specification, the contract between the lab and the buyer. The two figures buyers should watch are area-percent purity and EU/mg endotoxin.
| Parameter | Method | Acceptance criterion |
|---|---|---|
| Identity (mass) | ESI-MS | Within ±1 Da of theoretical monoisotopic mass |
| Purity (HPLC) | RP-HPLC, UV 210/214 nm | ≥99.0% area percent |
| Net peptide content | UV 205/280 nm | Reported numerically per batch |
| Bacterial endotoxin | USP <85> (LAL) | Numerical EU/mg result |
| Residual solvents | GC per ICH Q3C | Within ICH Q3C class 2/3 limits |
| Heavy metals | ICP-MS | Reported in ppb where catalysts used |
The third-party verification model
Samples are sent from the Kylo synthesis facility to FreedomDiagnostics, run on their instruments by their personnel, and issued under their letterhead with a unique verification ID per submission. A failing result from an independent lab generates an external record, which is the point. Methods are compendial and verified per USP <1225>/<1226> and ISO/IEC 17025:2017.
When a batch fails
- 01 · Investigation, the result is reviewed with FreedomDiagnostics to confirm it's real and not a method anomaly; retest where appropriate.
- 02 · Root-cause review, the synthesis batch record is reviewed against the result (coupling failure, incomplete cleavage, water source, handling).
- 03 · Disposition, the batch is reworked (second prep-HPLC pass + retest) or rejected, removed from inventory, and destroyed under a documented destruction record.
Where Kylo sits in the quality tier
Pharmaceutical-grade APIs
cGMP per FDA 21 CFR 211, full chain-of-custody, sterile, validated/filed methods. (Bachem, PolyPeptide, CordenPharma.)
Research-use with third-party verification
Written SOPs, published specs, compendial methods, independent lab results, traceable records.
Manufacturer-issued COAs only
In-house tested, own letterhead, cannot be independently verified at lot level.
No batch-level documentation
Generic product-level COAs, missing chromatograms/endotoxin, Pass/Fail without numbers, the bottom of the market.
What buyers can verify directly
- The COA Library, searchable by lot number.
- The FreedomDiagnostics verification ID printed on every COA.
- The written specification per compound, on request.
- The analytical method conditions printed on each chromatogram and mass spec.
- The batch retention policy.
